Epigenomics AG (Epigenomics AG) Days Payable : 28,363.54 (As of Jun. 2023)

View and export this data going back to . Start your Free Trial

What is Epigenomics AG Days Payable?

Epigenomics AG's average Accounts Payable for the three months ended in Jun. 2023 was $1.87 Mil. Epigenomics AG's Cost of Goods Sold for the three months ended in Jun. 2023 was $0.01 Mil. Hence, Epigenomics AG's Days Payable for the three months ended in Jun. 2023 was 28,363.54.

The historical rank and industry rank for Epigenomics AG's Days Payable or its related term are showing as below:

EPGNF' s Days Payable Range Over the Past 10 Years
Min: 336.41 Med: 1265.05 Max: 6154.25
Current: 6154.25

During the past 13 years, Epigenomics AG's highest Days Payable was 6154.25. The lowest was 336.41. And the median was 1265.05.

EPGNF's Days Payable is ranked better than
98.54% of 206 companies
in the Medical Diagnostics & Research industry
Industry Median: 68.79 vs EPGNF: 6154.25

Epigenomics AG's Days Payable increased from Jun. 2022 (2,282.63) to Jun. 2023 (28,363.54). It may suggest that Epigenomics AG delayed paying its suppliers.

Epigenomics AG Days Payable Historical Data

The historical data trend for Epigenomics AG's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Epigenomics AG Days Payable Chart

Epigenomics AG Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Days Payable

Get a 7-Day Free Trial

995.19

2,074.40

2,440.94

1,579.69

6,205.00

Epigenomics AG Quarterly Data
	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23
Days Payable	Get a 7-Day Free Trial															2,282.63	2,363.63	7,919.20	7,886.28	28,363.54

Competitive Comparison of Epigenomics AG's Days Payable

For the Diagnostics & Research subindustry, Epigenomics AG's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Epigenomics AG's Days Payable Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Epigenomics AG's Days Payable distribution charts can be found below:

* The bar in red indicates where Epigenomics AG's Days Payable falls into.

Epigenomics AG Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

Epigenomics AG's Days Payable for the fiscal year that ended in Dec. 2022 is calculated as

	Days Payable (A: Dec. 2022 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (A: Dec. 2021 )	+	Accounts Payable (A: Dec. 2022 ))	/	count )	/	Cost of Goods Sold (A: Dec. 2022 )	*	Days in Period
=	( (0.568	+	3.75)	/	2 )	/	0.127	*	365
=	2.159					/	0.127	*	365
=	6,205.00

Epigenomics AG's Days Payable for the quarter that ended in Jun. 2023 is calculated as:

	Days Payable (Q: Jun. 2023 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (Q: Mar. 2023 )	+	Accounts Payable (Q: Jun. 2023 ))	/	count )	/	Cost of Goods Sold (Q: Jun. 2023 )	*	Days in Period
=	( (3.164	+	0.566)	/	2 )	/	0.006	*	365 / 4
=	1.865					/	0.006	*	365 / 4
=	28,363.54

Epigenomics AG Days Payable Related Terms

Thank you for viewing the detailed overview of Epigenomics AG's Days Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

Epigenomics AG (Epigenomics AG) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Epigenomics AG (OTCPK:EPGNF) » Definitions » Days Payable

Comparable Companies

Traded in Other Exchanges

ECX:Germany

Address

Geneststrasse 5, Berlin, BB, DEU, 10829

Website

https://www.epigenomics.com

Epigenomics AG is a molecular diagnostics company, that focuses on developing and commercializing in vitro diagnostic liquid biopsy tests for the screening, early detection, and diagnosis of cancer. The company develops and markets procedures and devices for the production in quantity of particular epigenetic parameters such as DNA methylation patterns as well as the information technology bases necessary for their procurement and evaluation. It is engaged in the development of novel molecular diagnostic products for cancer. The company products include Epi proColon, Epi BiSKit, HCCBloodTest, and Epi proLung. The company operates in Europe, Asia, and North America, majority of its revenue derives from Asia.

Epigenomics AG (Epigenomics AG) Headlines

From GuruFocus

Encode Ideas, L.P. to host Virtual 1x1 Webinar with Epigenomics AG (ECX.DE, EPGNF) on Tuesday, July 28th at 10:30 AM ET

By ACCESSWIRE ACCESSWIRE • 07-23-2020